ArticleCureus2026
Two Cases of Intentional Sodium Nitrite Poisoning With Contrasting Outcomes: The Critical Role of Early Recognition and Treatment.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intentional sodium nitrite poisoning may result in severe methemoglobinemia and life-threatening tissue hypoxia. We present two cases of intentional sodium nitrite ingestion with markedly different clinical outcomes, both managed at the same center and treated with methylene blue at different stages of clinical deterioration, thereby illustrating the potential importance of early recognition and treatment timing. The first patient was a 31-year-old man without a significant medical history who was found unconscious in his apartment after an unknown interval following ingestion; therefore, the time to emergency medical intervention could not be determined. He remained in cardiac arrest upon admission, with ongoing advanced life support, mechanical ventilation, and mechanical chest compressions. Methylene blue was administered intravenously immediately upon admission to the Toxicology Unit in two doses of 2 mg/kg (170 mg each) given 15 minutes apart, corresponding to a total cumulative dose of 4 mg/kg (340 mg). Initial laboratory investigations revealed an extremely high methemoglobin level of 97% (typical reference value: <2%), profound acidosis (pH 6.684), severe hyperlactatemia (29 mmol/L), and critically impaired oxygenation. Return of spontaneous circulation was not achieved, and the patient was pronounced dead 40 minutes after admission to the Toxicology Unit. The second patient was a 22-year-old woman with a history of personality disorder who ingested 7.5 g of sodium nitrite and promptly informed her family, enabling rapid activation of Emergency Medical Services (EMS). Methylene blue was administered intravenously approximately 50 minutes after ingestion in two doses of 2 mg/kg (160 mg each) given 15 minutes apart, corresponding to a total cumulative dose of 4 mg/kg (320 mg). Her initial methemoglobin concentration was 66.1%, and antidotal treatment resulted in rapid clinical and laboratory improvement. Despite requiring prolonged intensive care and treatment for pneumonia, she was discharged after 22 days without neurological sequelae. These cases highlight the critical importance of early recognition and prompt initiation of antidotal therapy in sodium nitrite poisoning. The markedly different outcomes observed in two patients exposed to the same toxic agent suggest that prolonged untreated tissue hypoxia may have a greater influence on prognosis than the absolute methemoglobin concentration alone. Although no firm conclusions can be drawn from two cases, the findings suggest that early methylene blue administration combined with intensive supportive care may be associated with favorable outcomes even in severe poisoning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.